Global Infectious Disease Diagnostics Market

Infectious Disease Diagnostic Market size was valued at USD 37.76 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 4.6 % through 2024 to 2030, reaching nearly USD 51.73 Bn.

Market Overview:

The report explores the Infectious Disease Diagnostic market’s segments (Techniques, Disease, and End-User). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2023. The report investigates the Infectious Disease Diagnostic market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Infectious Disease Diagnostic market’s contemporary competitive scenario.To know about the Research Methodology:-Request Free Sample Report

Infectious Disease Diagnostic Market Dynamics:

The global prevalence of infectious diseases:

The occurrence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are accountable for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, along with the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period.

The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics; hence, they had a positive impact on this market. Additionally, the increase in government funding, rising healthcare costs, and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also intensify the overall growth of the market. Though, the lack of adequate reimbursement mechanisms in developed economies and some emerging economies hinders the market’s growth.

The major and growing trend in the epidemiology market is the increasing adoption of technologically advanced visual diagnostic equipment in healthcare organizations in emerging economies is expected to generate profitable opportunities for the market. On the other hand, the rising health care costs in developed economies and a lack of awareness about infectious diseases have the potential to challenge the market’s growth.

Growing opportunities in growing economies:

Developing economies such as India, South Korea, Brazil, and Mexico are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improved healthcare infrastructure, increased disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.

Unfavorable reimbursement scenario:

The inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. Most diagnostic companies face a major challenge in commercializing their tests is getting health insurers to pay for them. These are some of the factors that are leading through the forecast period.

Infectious Disease Diagnostic Market Trends:

The significant increase in the number of medical laboratories, for infectious disease diagnostic testing, anticipates the growth market’s growth Government of India, 2020, announced the launch of three state-of-the-art high throughput Indian Council of Medical Research labs in Kolkata, Mumbai, and Noida, to increase the COVID-19 testing capacity. Apart from COVID-19 tests, these labs are also used for other diagnostic tests for infectious diseases such as HIV, hepatitis, tuberculosis, and dengue. Also, a rise in awareness among individuals for early diagnosis and management of infectious diseases, and an increase in the number of information technology systems to develop advanced diagnostic devices are expected to provide remunerative opportunities for the expansion of the global infectious disease diagnostic market during the forecast period.

Disease diagnostics are used for confirmation of the disease in form of a quick, precise test result. Being time-consuming, disease diagnostics are on the rise for the past few years. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests. Moreover, the incidences of malaria, flu, AIDS, and other diseases are also rising, creating a robust demand for infectious disease diagnostics. With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests to awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to the market growth through the forecast period.

Infectious Disease Diagnostic Market Segment Analysis:

By technique, the Infectious Disease Diagnostic market is segmented into lateral flow immunoassay, agglutination test, flow-through test/Immuno-concentration assay, molecular diagnostics, and others. The lateral flow immunoassay segment has dominated the largest market share accounting for xx% in 2023 and is expected to grow during the forecast period.

The dominance is attributable to the faster diagnosis and availability of the test kits in decentralized settings. Additionally, increased product launch due to COVID-19 has also contributed to the growth of the segment. The molecular diagnostics segment is projected to register a higher CAGR by 2030 because of the increasing application of concepts such as RT-PCR, ELISA, etc., in infectious disease POC testing kits. Additionally, the rise in the number of FDA approvals is likely to boost the sales growth of the segment.

Additionally, the flow-through test/immunoconcentration assay segment is expected to grow at a considerable CAGR during the forecast period because of the increasing number of market players engaged in introducing advanced kits based on the flow-through technique in the global market. Also, growing awareness about the application of agglutination tests for infectious disease diagnosis is expected to push forward the agglutination test segment during the forecast period.

By diseases, the Infectious Disease Diagnostic market is segmented into HIV, hepatitis B virus, pneumonia/streptococcus associated infections, respiratory syncytial virus, influenza, Clostridium difficile infections (CDI), hepatitis C virus, MRSA, tuberculosis, and others. The clostridium difficile infections (CDI) segment has dominated the largest market share accounting for xx% in 2023.

The increasing burden of under-diagnosis and the incidence rate of infectious diseases globally has led to the rapid adoption of POC testing kits leading to increased growth. This is because of the huge volume of sales of POC kits for CDI diagnosis. CDI is the most common infection found in patients who are in hospitals and critical care units. This has mainly contributed to the demand for CDI diagnosis kits. Influenza being the leading cause of acute respiratory infection has led to a higher adoption rate of these diagnostics products for timely disease management.

Additionally, the growing R&D investments for advanced POC kits in developing nations are anticipated to boost the growth of the influenza segment through the forecast period.

Infectious Disease Diagnostic Market Regional Insights:

The North American region emerged as the dominant regional market share accounting for xx% and expand at a CAGR of 7.6% over the forecast period. This is because of the highly developed healthcare system, with the prevalence of infectious diseases, large numbers of major national clinical laboratories, and easy access to technologically advanced equipment. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the higher demand for infectious diseases diagnostic kits because of the increasing patient pool and rising awareness among people.

Asia Pacific region is expected to be the second dominant region in this market. This is because the governments of various countries in the Asia Pacific are increasingly registering a higher demand for infectious diseases diagnostic kits resulting in the largest market in this region, the MEA market will also witness a significantly growing market owing to the growth of governmental initiatives.

The objective of the report is to present a comprehensive analysis of the global Infectious Disease Diagnostic Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear, futuristic view of the industry to the decision-makers.

The reports also help in understanding the Infectious Disease Diagnostic Market dynamic and structure by analyzing the market segments and projecting the Infectious Disease Diagnostic Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Infectious Disease Diagnostic Market make the report investor’s guide.

Infectious Disease Diagnostic Industry Ecosystem

Infectious Disease Diagnostic Market Scope: Inquire before buying

Infectious Disease Diagnostic Market by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Infectious Disease Diagnostic Market Key Players:

1. F. Hoffmann-La Roche Ltd
2. Abbott Diagnostics
3. bioMérieux SA
4. Becton-Dickinson & Company
5. Siemens Healthineers
6. Thermo Fischer Scientific, Inc.
7. Bio-Rad Laboratories
8. Sysmex Corporation
9. Beckman Coulter
10.Danaher Corporation
11.Alere Inc.
12.Chembio Diagnostics Inc.
13.Cepheid Inc
14.DiaSorin
15.Meridian Bioscience
16.Trinity Biotech
17.Sekisui Diagnostics
18.Quidel Corporation
19.MedMira, Inc.
20.Calypte Biomedical Corporation
21.Johnson & Johnson Services Inc.
22.Hologic, Inc.
23.Qiagen N.V.
24.Sofina s.a.
25.Ingersoll-Rand plc.

Frequently Asked Questions:

1] What segments are covered in the Infectious Disease Diagnostic Market report?
Ans. The segments covered in the Infectious Disease Diagnostic Market report are based on Techniques, Disease, and End-User.

2] Which region is expected to hold the highest share in the Infectious Disease Diagnostic Market?
Ans. The North American region is expected to hold the highest share in the Infectious Disease Diagnostic Market.

3] What is the market size of the Infectious Disease Diagnostic Market by 2030?
Ans. The market size of the Infectious Disease Diagnostic Market by 2030 is US$ 51.73 Bn.

4] What is the forecast period for the Infectious Disease Diagnostic Market?
Ans. The Forecast period for the Infectious Disease Diagnostic Market is 2024-2030.

5] What was the market size of the Infectious Disease Diagnostic Market in 2023?
Ans. The market size of the Infectious Disease Diagnostic Market in 2023 was US$ 37.76 Bn.